Then we found that MEG3 methylation in plasma was an effective biomarker for the diagnosis of CIN III (cervical intraepithelial neoplasia), HR-HPV (High risk-Human papillomavirus) infection and lymph node metastasis. Here, MEG3 is linked to uterine cervix carcinoma in situ.